A perspective article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association looks at challenges for new Alzheimer’s drugs. … read more
A conference abstract presented at the Alzheimer’s Association International Conference looks at red meat intake and dementia risk. Dr Richard … read more
Scientists react to findings presented at the Alzheimer’s Association International Conference (AAIC) 2024 about continuous treatment with lecanemab. Prof … read more
A conference abstract at the Alzheimer’s Association International Conference looks at weight loss drug liraglutide and Alzheimer’s disease. Dr … read more
Scientist comment on the EMA decision on the use of lecanemab for Alzheimer’s disease. Prof Robert Howard, Professor of … read more
A study published in Nature Medicine looks at the genetic variants and Alzheimer’s disease. Prof Jonathan Schott, Chief Medical Officer at … read more
A study published in The BMJ looks at antipsychotic use in people with dementia. Dr Richard Oakley, Associate Director of … read more
A study published in Stem Cell Reports looks at a stem cell transplant in mice and transmission of a familial form of … read more
Scientists react to news that the FDA are delaying a decision on the Alzheimer’s drug Donanemab. Prof Robert Howard, … read more
A study published in Nature Aging looks at possible plasma protein biomarkers for dementia risk. Dr Sheona Scales, Director of Research … read more
A study published in Neurology looks at erectile dysfunction drugs and risk of Alzheimer’s Disease. Dr Francesco Tamagnini, Neurophysiologist at the … read more
A study published in Nature Medicine looks at Alzheimer’s Disease in recipients of cadaveric pituitary-derived growth hormone. Dr Richard Oakley, Associate … read more
A study published in JAMA Neurology looks at Tau immunoassays for Alzheimer’s Disease Dr Richard Oakley, Associate Director of Research and … read more
A study published in JAMA Otolaryngology–Head & Neck Surgery looks at hearing loss and hearing aid use and the risk of dementia. … read more
The way dementia is diagnosed has barely changed for nearly two decades, and here’s the shocker: at least a third … read more
A study published in Current Biology looks at navigational mistakes as a possible sign of Alzheimer’s disease. Dr Leah Mursaleen, Head … read more
A study published in Cell Metabolism looks at time-restricted feeding and memory in mouse models of Alzheimer’s disease. Dr … read more
Results from Eli Lilly’s TRAILBLAZER-ALZ 2 Randomized Clinical Trial looking at the use of donanemab in early symptomatic Alzheimer’s disease … read more
The U.S. Food and Drug Administration (FDA) has converted lecanemab from an accelerated approval to a traditional approval for the … read more
A press release from Eli Lilly states that their antibody treatment, donanemab, significantly slowed cognitive and functional decline in phase … read more
